Immunization with an amyloid β-peptide fragment reduces learning and memory impairments in mice, and this approach may eventually be used to prevent and/or treat this disease in people.
They explored the role of βHB in regulating the solubility of unstable and misfolded proteins, specifically neurodegeneration-related proteins such as amyloid-β, across various models.